- Obtained a dismissal with prejudice for the former CEO of a medical products and equipment company in a securities class action in the E.D.N.Y. This follows our representation of the individual and others in a related MDL involving a recall of one of the company’s products.
- Representing healthcare systems and interventional cardiologists in defending against an FCA litigation in the S.D.N.Y. revolving around the joint participation requirement of guidance related to Transcatheter Aortic Valve Replacement (TAVR) procedures.
- Defended against a multiyear DOJ investigation of an international carrier for alleged cargo handling violations. After conducting a detailed presentation to the U.S. Attorney’s Office for the District of New Jersey, including the provision of a comprehensive white paper, the Government declined prosecution in the matter.
- Represented the former head of sales at OneTaste, a San Francisco-based wellness company, in her defense against an indictment, pending in the E.D.N.Y., which charges conspiracy to commit forced labor.
- Representing a former assistant U.S. attorney from the District of Delaware, before the House Judiciary Committee in connection with requested testimony regarding the Hunter Biden investigation.
- Representing an American multinational information technology services and consulting company in connection with an ongoing criminal prosecution of two former executives of Cognizant for violations of the Foreign Corrupt Practices Act.
- Represented New Jersey Senator Robert Menendez against government charges of bribery and corruption that were dismissed with prejudice following a three-month trial that resulted in a hung jury.
- Obtained a unanimous precedential decision from the Third Circuit, which rejected efforts by a consortium of news media seeking the disclosure of names in a letter containing a list of alleged unindicted co-conspirators connected to the New Jersey “Bridgegate” scandal.
- Retained by U.S. Soccer to conduct an internal investigation in an allegation against the U.S. Men’s National Team head coach Gregg Berhalter and an allegation against others related to interactions with members of the U.S. Soccer staff.
- Represented a device manufacturer in an FCA investigation regarding speaker fees, lavish meals, and other remuneration paid to a physician consultant. Although the physician was under criminal investigation and ultimately pleaded guilty to health care fraud, we successfully negotiated a speedy civil resolution with the government for less than the cost of defense, without a monitor or corporate integrity agreement.
- Phone: +1 212 210 9420
- Email: jenny.kramer@alston.com
- Represented a medical products company in an internal investigation.
- Represented a physician in a DOJ investigation regarding allegations of conspiracy to commit health care fraud.
- Represented a medical staffing company in an internal investigation regarding allegations of Medicare and Medicaid fraud.
- Represented an individual in a DOJ investigation, with related a FCA matter, regarding the marketing and promotional practices of a medical devices company.
- Represented an individual in a DOJ investigation regarding allegations of Medicare and Medicaid fraud which resulted in a declination.
- Represented current and former employees of a pharmaceutical company in a large-scale DOJ investigation relating to diversion.
- Represented a dietary supplement retailer in a DOJ investigation regarding its sale of potentially unlawful dietary supplements.
- Represented the former CFO of a major technology corporation in SEC enforcement action pending in the S.D.N.Y.
- Represented an individual charged with racketeering and wire fraud conspiracy in a DOJ investigation into soccer’s international governing body, FIFA.
- Represented a chief engineer at a national technology company in a DOJ criminal investigation which resulted in a declination.
- Represented an international financial institution in parallel investigations by the DOJ, New York Department of Financial Services, and other regulatory authorities.
Jenny Kramer is a co-leader of the White Collar, Government & Internal Investigations Team, who focuses her practice on white collar criminal defense, SEC and other regulatory enforcement, internal investigations, and complex commercial litigation. She represents financial institutions, corporations, and individuals across a range of industries in international and domestic criminal matters, including corruption and bribery allegations, money laundering, the Bank Secrecy Act, FCPA, FCA, and health care and securities. Jenny made headlines as part of the defense team representing U.S. Sen. Robert Menendez against government charges of bribery and corruption, where the charges were dismissed with prejudice following a three-month trial. Jenny also made news by winning a unanimous decision from the Third Circuit overturning a lower court ruling and vacating a decision to unseal the identity of client “John Doe” in the Bridgegate scandal in New Jersey.
Jenny served as an assistant U.S. attorney in the District of New Jersey for more than nine years. She conducted and prosecuted large-scale, complex financial fraud investigations, including market manipulation and investment schemes, securities, corporate, mail and wire fraud, and insider trading. Jenny worked closely with the SEC in joint investigations yielding administrative and criminal penalties. She tried to verdict numerous cases involving charges of conspiracy, fraud, obstruction of justice, public corruption, and violations of the Federal Election Campaign Act.
-
Speaking Engagement February 26, 2025Health Care Fraud and Abuse SeminarJenny Kramer is a guest lecturer for this seminar at Georgetown University School of Law.Speaking Engagement February 26, 2025Health Care Fraud and Abuse SeminarJenny Kramer is a guest lecturer for this seminar at Georgetown University School of Law.
-
In the News February 4, 2025Law360 | DLA Piper Partner to Testify at Cognizant Evidence HearingJenny Kramer, Rachel Finkel, and Scott O’Brien are noted for representing Cognizant Technology Solutions in a criminal bribery case.In the News February 4, 2025Law360 | DLA Piper Partner to Testify at Cognizant Evidence HearingJenny Kramer, Rachel Finkel, and Scott O’Brien are noted for representing Cognizant Technology Solutions in a criminal bribery case.
-
Press Release November 15, 2024Alston & Bird Secures Litigation Win for SandozOn November 4, Alston & Bird secured over $70 million in damages for client Sandoz in litigation against biopharmaceutical firm United Therapeutics Corp. (UTC). In 2019, Sandoz filed a suit alleging UTC blocked the sale of a generic version of hypertension medication by colluding with the manufacturer of infusion pumps for injecting UTC’s brand-name hypertension drug Remodulin to muscle out Sandoz’s generic alternative. Following a three-day bench trial, U.S. District Judge Brian R. Martinotti found Sandoz lost profits of $137.2 million and entered a judgment in favor of Sandoz, awarding damages of $61.6 million, plus prejudgment interest of $8.9 million, on its breach of contract claim against UTC. The win was featured in The American Lawyer’s Litigator of the Week, Law360’s Legal Lions column, and The New Jersey Law Journal.Press Release November 15, 2024Alston & Bird Secures Litigation Win for SandozOn November 4, Alston & Bird secured over $70 million in damages for client Sandoz in litigation against biopharmaceutical firm United Therapeutics Corp. (UTC). In 2019, Sandoz filed a suit alleging UTC blocked the sale of a generic version of hypertension medication by colluding with the manufacturer of infusion pumps for injecting UTC’s brand-name hypertension drug Remodulin to muscle out Sandoz’s generic alternative. Following a three-day bench trial, U.S. District Judge Brian R. Martinotti found Sandoz lost profits of $137.2 million and entered a judgment in favor of Sandoz, awarding damages of $61.6 million, plus prejudgment interest of $8.9 million, on its breach of contract claim against UTC. The win was featured in The American Lawyer’s Litigator of the Week, Law360’s Legal Lions column, and The New Jersey Law Journal.
-
In the News November 15, 2024Law.com | Litigator of the Week Runners-Up and Shout-OutsAlston & Bird is noted for securing a $70 million judgment for Sandoz Inc. and a $7.3 million jury verdict for Cigna Health & Life Insurance Co.In the News November 15, 2024Law.com | Litigator of the Week Runners-Up and Shout-OutsAlston & Bird is noted for securing a $70 million judgment for Sandoz Inc. and a $7.3 million jury verdict for Cigna Health & Life Insurance Co.
-
Speaking Engagement October 23–25, 2024Civil & Criminal Healthcare Fraud EnforcementJenny Kramer is speaking on the “New Cooperation Policies” panel on October 24 at this event hosted by Cambridge Forums.Speaking Engagement October 23–25, 2024Civil & Criminal Healthcare Fraud EnforcementJenny Kramer is speaking on the “New Cooperation Policies” panel on October 24 at this event hosted by Cambridge Forums.
-
Press Release October 7, 2024Alston & Bird Obtains Dismissal with Prejudice for Former CEO of Philips RespironicsAlston & Bird obtained a dismissal with prejudice for John Frank, the former CEO of health technology company Philips Respironics, in a securities class action in the Eastern District of New York. All claims against Frank were dismissed with prejudice after years-long litigation that culminated in argument on the motion in April.Press Release October 7, 2024Alston & Bird Obtains Dismissal with Prejudice for Former CEO of Philips RespironicsAlston & Bird obtained a dismissal with prejudice for John Frank, the former CEO of health technology company Philips Respironics, in a securities class action in the Eastern District of New York. All claims against Frank were dismissed with prejudice after years-long litigation that culminated in argument on the motion in April.
-
Speaking Engagement September 26, 2024GIR Live: Annual Investigations Meeting New York 2024Jenny Kramer is speaking on the “Enhanced Regulatory Scrutiny of Healthcare Companies” panel at this annual meeting hosted by the Global Investigations Review.Speaking Engagement September 26, 2024GIR Live: Annual Investigations Meeting New York 2024Jenny Kramer is speaking on the “Enhanced Regulatory Scrutiny of Healthcare Companies” panel at this annual meeting hosted by the Global Investigations Review.
-
In the News September 24, 2024Law360 | Philips Must Face Investor Suit over FDA Compliance IssuesJenny Kramer, Joseph Tully, and Scott O’Brien are noted for representing John Frank, former CEO of Koninklijke Philips.In the News September 24, 2024Law360 | Philips Must Face Investor Suit over FDA Compliance IssuesJenny Kramer, Joseph Tully, and Scott O’Brien are noted for representing John Frank, former CEO of Koninklijke Philips.
-
Speaking Engagement August 27, 2024Hot Topics in White-Collar CrimeJenny Kramer is speaking at the “Hot Topics in White-Collar Crime” webinar hosted by the New Jersey State Bar Association.Speaking Engagement August 27, 2024Hot Topics in White-Collar CrimeJenny Kramer is speaking at the “Hot Topics in White-Collar Crime” webinar hosted by the New Jersey State Bar Association.
-
Press Release June 6, 2024Alston & Bird Increases Practices and Attorneys Recognized in Chambers USA 2024Alston & Bird has received significant recognition in the 2024 edition of Chambers USA: America’s Leading Lawyers for Business, with 73 practice rankings and 153 leading lawyer listings.Press Release June 6, 2024Alston & Bird Increases Practices and Attorneys Recognized in Chambers USA 2024Alston & Bird has received significant recognition in the 2024 edition of Chambers USA: America’s Leading Lawyers for Business, with 73 practice rankings and 153 leading lawyer listings.
弁護士登録
- ニューヨーク州
- New Jersey
学歴
- Seton Hall University (法務博士, 2001)
- Oberlin College (B.M., 1997)
所属団体・組織
- Top 100 Women in Investigations 2018, Global Investigations Review
- Chambers USA: America’s Leading Lawyers for Business – Litigation: White Collar Crime & Government Investigations (2021 – 2024)
- The Best Lawyers in America® (2023 – 2025)